Table 4.

Treatment of Manifestations in Individuals with Spinocerebellar Ataxia Type 14

Manifestation/
Concern
TreatmentConsiderations/Other
Ataxia Assessment & care by physical medicine, OT/PT
  • PT (balance exercises, gait training, & muscle strengthening) to maintain mobility & function
  • OT to optimize activities of daily living
  • Consider adaptive devices to maintain/improve independence in mobility (e.g., canes, walkers, ramps to accommodate motorized chairs), feeding (e.g., weighted eating utensils), & dressing (e.g., dressing hooks)
  • Home adaptations to prevent falls (e.g., grab bars, raised toilet seats)
  • Weight control & physical activity to avoid obesity & related difficulties w/mobility
Axial myoclonus Clonazepam or valproic acidMay be effective 1
Dysarthria Speech & language therapyConsider alternative communication methods as needed (e.g., writing pads, digital devices).
Dysphagia Modify food consistency to ↓ aspiration risk.Video esophagram may help define best consistency.
Poor weight gain Nutrition assessmentConsider nutritional & vitamin supplementation to meet dietary needs.
Intellectual
disability
Assessment by educational psychologist & IEP evalEnsure appropriate social work involvement to connect families w/local resources, respite, & support.

IEP = individualized education plan; OT = occupational therapy; PT = physical therapy

1.

From: Spinocerebellar Ataxia Type 14

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.